Search - tctmd.com

Displaying 621 - 640 of 1242

Sort: Relevancy | Date

Presentation ECHO 2018

Strengths and Weaknesses of Mitral Regurgitation Quantitation: Is there a difference between primary and secondary?

Presenter: Linda D. Gillam

April 19, 2018

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

Presentation ECHO 2018

Aortic Regurgitation Nuances in Echo

Presenter: Jae K. Oh

April 19, 2018

Presentation ECHO 2018

The MR Decision Pathway: It's All About The Journey

Presenter: Rebecca T. Hahn

April 18, 2018

Presentation ECHO 2018

Mitral regurgitation: Nuances of Imaging MR in Chronic Heart Failure

Presenter: Linda D. Gillam

April 18, 2018

Presentation ECHO 2018

Mitral Regurgitation: The Importance of Morphology

Presenter: Stephen H. Little

April 18, 2018

Presentation ECHO 2018

Quantification of Valvular Re ur itation: Vena Contracta, ERO, Regurgitant Volume ....

Presenter: Neil J. Weissman

April 18, 2018

News Featured Fellow

Samit Bhatheja, MD, MPH

Yael L. Maxwell

April 11, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

Michael O'Riordan

February 27, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

Manuscript

Elixhauser Comorbidity Score Is the Best Risk Score in Predicting Survival After Mitraclip Implantation

December 01, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

Advertisement

Strengths and Weaknesses of Mitral Regurgitation Quantitation: Is there a difference between primary and secondary?

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

Aortic Regurgitation Nuances in Echo

The MR Decision Pathway: It's All About The Journey

Mitral regurgitation: Nuances of Imaging MR in Chronic Heart Failure

Mitral Regurgitation: The Importance of Morphology

Quantification of Valvular Re ur itation: Vena Contracta, ERO, Regurgitant Volume ....

Samit Bhatheja, MD, MPH

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Elixhauser Comorbidity Score Is the Best Risk Score in Predicting Survival After Mitraclip Implantation

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content